Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue	$ 0	$ 0	$ 0	$ 0
Expenses:
Consulting	0	0	24,021	0
Research and development	295,830	93,270	575,999	130,180
Selling, general and administrative (Note 8)	113,607	83,605	319,132	204,447
Stock-based compensation (Note 7)	169,373	120,098	537,019	120,098
Total expenses	578,810	296,973	1,456,171	454,725
Loss from operations	(578,810)	(296,973)	(1,456,171)	(454,725)
Other income
Interest income	0	0	0	96
Nonoperating Income (Expense), Total	0	0	0	96
Net loss	$ (578,810)	$ (296,973)	$ (1,456,171)	$ (454,629)
Net loss per share - basic and diluted (in dollars per share)	$ (0.01)	$ (0.00)	$ (0.02)	$ (0.01)
Weighted average number of common shares outstanding – basic and diluted (in shares)	91,422,569	86,522,569	89,476,981	78,165,426